ATAD1 and malaria: Although these patients had robust levels of antibodies specific for other P. falciparum antigens, including three malaria merozoite surface proteins (MSP1, MSP2, and MSP3), the levels of detectable circulating α-HRP2 antibodies were no different from those of malaria-naïve control patients from the United States.